Treatment of racemose neurocysticercosis

Samuel McClugage, Rachael Lee, Bernard Camins, Juan Mercado-Acosta, Martin Rodriguez, Kristen Riley

Research output: Contribution to journalArticlepeer-review

1 Scopus citations


Background: Neurocysticercosis (NCC) is a common parasitic infection of the central nervous system, caused by the tapeworm Taenia solium. It is endemic to certain parts of the world, including Central America, South America, Asia, and Africa. The racemose form, characterized by extraparenchymal location, increased morbidity and mortality, and large loculated cystic lesions, is rarely seen in industrialized countries, such as the United States. The management of racemose neurocysticercosis (RNCC) differs from that of the typical parenchymal variant. The ideal course of treatment is debated by experts, but typically includes either surgical intervention with subsequent medical therapy or medical therapy alone. Case Description: We present the case of a 34-year-old male diagnosed with RNCC and treated successfully with surgical cyst drainage, resection, and subsequent medical therapy. Conclusion: Currently, no standardized evidence-based protocol exists that dictate appropriate treatment for extraparenchymal or racemose NCC. We present a case of RNCC treated successfully with surgical and medical intervention. Further research encompassing well-designed clinical trials is necessary to delineate appropriate and standardized protocols for treatment of this disease.

Original languageEnglish
Article number168
JournalSurgical Neurology International
Issue number1
StatePublished - 2017
Externally publishedYes


  • Cyst rupture
  • Taenia solium
  • medication
  • neurocysticercosis
  • racemose
  • surgery
  • treatment


Dive into the research topics of 'Treatment of racemose neurocysticercosis'. Together they form a unique fingerprint.

Cite this